One year findings from Phase I/II clinical study support the feasibility of transplanting stem-cell derived dopamine progenitor cells into the brain of Parkinson’s disease patients. The post Stem Cell Therapy Shows Promise in First Human Parkinson’s Disease Trial appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
Pluripotent stem cell trial for Huntington’s disease
Jascayd gains UK licence for treatment of pulmonary...
Teva submits FDA application for paediatric Tourette...
Medical-Commercial alignment in rare disease launches:...
Top 10 Best-Selling Drugs 2026
Virtual Cells Go Multiscale to Predict Complex Biology
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.